| 1 |
methotrexate
((商品名))(抗悪性腫瘍薬) メソトレキセート, (葉酸代謝拮抗薬;白血病・関節リウマチ治療) メトトレキサート, メソトレキサート, メトトレキセート
(10425 回)
|
Rheumatology
リウマチ学
(2105 回)
|
RA (2473 回)
DHFR (394 回)
ALL (391 回)
|
1962 A comparative study of 5-fluorouracil (FU), 5-fluorodeoxyuridine (FUDR), and methotrexate (MTX)-progress report.
|
| 2 |
mitoxantrone
(抗悪性腫瘍薬;アントラサイクリン系抗生物質) ミトキサントロン
(152 回)
|
Pharmacology
薬理学, 薬理, 薬品作用学
(20 回)
|
MS (17 回)
DOX (14 回)
EDSS (8 回)
|
1984 Comparative microscopic study of cardiotoxicity and skin toxicity of anthracycline analogs.
|
| 3 |
maitotoxin
(藻食魚より見出された高分子量の毒) マイトトキシン
(106 回)
|
Pharmacology
薬理学, 薬理, 薬品作用学
(22 回)
|
CTX (4 回)
CFP (3 回)
L-VDCC (3 回)
|
1983 Contractile response of the rabbit aorta to maitotoxin, the most potent marine toxin.
|
| 4 |
methoxamine
(α1刺激薬;末梢血管収縮) メトキサミン
(27 回)
|
Cardiology
心臓病学
(9 回)
|
eNOS (4 回)
NO (4 回)
PVL (4 回)
|
1985 Contribution of extracellular and intracellular calcium to the enhanced effect of an alpha-adrenergic agonist on amylase release from dispersed rat parotid cells.
|
| 5 |
Maurotoxin
(22 回)
|
Biochemistry
生化学, 生物化学
(15 回)
|
CTX (2 回)
Abu (1 回)
AgTx2 (1 回)
|
1997 Maurotoxin, a four disulfide bridge toxin from Scorpio maurus venom: purification, structure and action on potassium channels.
|
| 6 |
medical treatment with methotrexate
(13 回)
|
Gynecology
婦人科学, 産婦人科学
(3 回)
|
EP (5 回)
beta-hCG (2 回)
ALP (1 回)
|
1999 Electrical stimulation prolongs the survival days of leukemic mice treated with methotrexate.
|
| 7 |
mosquitocidal toxin
(12 回)
|
Microbiology
微生物学, 細菌学
(5 回)
|
ADPRTs (1 回)
btx (1 回)
EF-Tu (1 回)
|
1993 Cytotoxicity and ADP-ribosylating activity of the mosquitocidal toxin from Bacillus sphaericus SSII-1: possible roles of the 27- and 70-kilodalton peptides.
|
| 8 |
MTX group
(9 回)
|
Rheumatology
リウマチ学
(7 回)
|
RA (6 回)
CrI (3 回)
RCTs (3 回)
|
2005 Modification of pro- and antiinflammatory cytokines and vascular-related molecules by tumor necrosis factor-a blockade in patients with rheumatoid arthritis.
|
| 9 |
maintenance therapy with methotrexate
(6 回)
|
Neoplasms
新生物, 腫瘍
(4 回)
|
ALL (4 回)
6-MP (2 回)
BFM (1 回)
|
1976 [Pulmonary disease during mtx therapy in a.l.l. (author's transl)].
|
| 10 |
marine toxin maitotoxin
(6 回)
|
Drug Therapy
薬物療法, 薬物治療
(2 回)
|
CBF (1 回)
fMLP (1 回)
ROCC (1 回)
|
1983 Excitatory effect of the most potent marine toxin, maitotoxin, on the guinea-pig vas deferens.
|
| 11 |
methotrexate sodium
メトトレキサートナトリウム
(6 回)
|
Skin Diseases
(2 回)
|
ADA (1 回)
DLQI (1 回)
FAE (1 回)
|
1978 Methotrexate-induced renal failure and ineffectiveness of peritoneal dialysis.
|
| 12 |
methotrexate-treated
(6 回)
|
Pharmacology
薬理学, 薬理, 薬品作用学
(2 回)
|
BA (2 回)
ADRs (1 回)
CIA (1 回)
|
1988 Natural and Chang liver cell cytotoxic studies of methotrexate-treated psoriatic patients with liver cirrhosis.
|
| 13 |
Methylxanthines
(ホスホジエステラーゼ阻害作用を有する化合物の1群) メチルキサンチン
(6 回)
|
Chemistry
化学
(2 回)
|
CAF (2 回)
PTX (2 回)
TH (2 回)
|
1986 Methylxanthine, alcohol-free diet and fibrocystic breast disease: a factorial clinical trial.
|
| 14 |
methotrexate alone
(4 回)
|
Rheumatology
リウマチ学
(3 回)
|
ACR Pedi 75 (1 回)
BP (1 回)
CIMT (1 回)
|
2003 Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis.
|
| 15 |
methoxychlor
(殺虫剤) メトキシクロル
(4 回)
|
Biochemistry
生化学, 生物化学
(1 回)
|
DA (2 回)
ME (2 回)
5-HIAA (1 回)
|
2000 Possible estrogenic and/or antiandrogenic effects of methoxychlor on prolactin release in male rats.
|
| 16 |
high-dose-methotrexate
(3 回)
|
Radiology
放射線学, 放射線医学
(1 回)
|
CRT (1 回)
GC-MS (1 回)
MTXCL (1 回)
|
2002 Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy.
|
| 17 |
metaxin gene
(3 回)
|
Genetics
遺伝学
(1 回)
|
psGBA (1 回)
psMTX (1 回)
THBS3 (1 回)
|
1996 Structure and organization of the human metaxin gene (MTX) and pseudogene.
|
| 18 |
methohexital
(睡眠薬;短時間作用型;バルビツール酸系) メトヘキシタール
(3 回)
|
Pharmacology
薬理学, 薬理, 薬品作用学
(1 回)
|
ED (1 回)
GABAAR (1 回)
GCS (1 回)
|
1986 Barbiturates block divalent cation action potentials in leech nociceptive cells.
|
| 19 |
mitoxantrone dihydrochloride
(3 回)
|
Biomedical Engineering
生物医工学
(1 回)
|
BPNSs (1 回)
HA (1 回)
NIR (1 回)
|
2013 Engineering porous silicon nanostructures as tunable carriers for mitoxantrone dihydrochloride.
|
| 20 |
Mojave toxin
(3 回)
|
Molecular Biology
分子生物学
(2 回)
|
PLA2 (2 回)
nt (1 回)
|
1994 Genomic sequences encoding the acidic and basic subunits of Mojave toxin: unusually high sequence identity of non-coding regions.
|
| 21 |
polymer-methotrexate
(3 回)
|
Biocompatible Materials
(1 回)
|
3,4-DHBA (1 回)
FUdR (1 回)
HaCaT (1 回)
|
1987 Comparison of the inhibitory effects of hydroxyurea, 5-fluorodeoxyuridine, 3,4-dihydroxybenzylamine, and methotrexate on human squamous cell carcinoma.
|
| 22 |
5-methylthio-d-xylofuranose
(2 回)
|
Microbiology
微生物学, 細菌学
(1 回)
|
LAM (2 回)
CI (1 回)
TB (1 回)
|
2018 A Novel Sensitive Immunoassay Targeting the 5-Methylthio-d-Xylofuranose-Lipoarabinomannan Epitope Meets the WHO's Performance Target for Tuberculosis Diagnosis.
|
| 23 |
cytostatics--methotrexate
(2 回)
|
Medicine
医学, 医薬
(2 回)
|
DXR (2 回)
|
2000 Central action of some cytostatics--methotrexate (MTX) and doxorubicin (DXR). I. Long-term influence on the pain sensitivity and activity of brain dopaminergic system in mice.
|
| 24 |
drug-methotrexate
(2 回)
|
Neoplasms
新生物, 腫瘍
(1 回)
|
CV (1 回)
HA (1 回)
LRET (1 回)
|
1985 [Radioimmunoassay of the antitumor drug--methotrexate (MTX)].
|
| 25 |
margatoxin
(2 回)
|
Reproductive Medicine
生殖医学
(1 回)
|
CC (1 回)
CTX (1 回)
EC (1 回)
|
2002 Potassium channel antagonists influence porcine granulosa cell proliferation, differentiation, and apoptosis.
|
| 26 |
marrow toxicity of methotrexate
(2 回)
|
Rheumatic Diseases
(1 回)
|
MTHFR (2 回)
ATIC (1 回)
FPGS (1 回)
|
2006 Methylenetetrahydrofolate reductase and thymidylate synthase genotypes and risk of acute graft-versus-host disease following hematopoietic cell transplantation for chronic myelogenous leukemia.
|
| 27 |
matrix size
(2 回)
|
Radiology
放射線学, 放射線医学
(2 回)
|
MR (2 回)
CNR (1 回)
COC (1 回)
|
2002 Technical parameters affecting image characteristics in in vivo MR microscopy of the mouse.
|
| 28 |
maximal tolerated dose of methotrexate
(2 回)
|
Rheumatology
リウマチ学
(2 回)
|
RA (2 回)
HAQ (1 回)
HAQ-DI (1 回)
|
2000 Divergent effect of cyclosporine on Th1/Th2 type cytokines in patients with severe, refractory rheumatoid arthritis.
|
| 29 |
mediating transport of methotrexate
(2 回)
|
Biochemistry
生化学, 生物化学
(1 回)
|
PGE2 (1 回)
TCA (1 回)
|
1991 Evidence for the facilitated transport of methotrexate polyglutamates into lysosomes derived from S180 cells. Basic properties and specificity for polyglutamate chain length.
|
| 30 |
metaxin
(2 回)
|
Genetics
遺伝学
(1 回)
|
GBA (2 回)
SCAMP37 (1 回)
THBS3 (1 回)
|
1997 Identification of three additional genes contiguous to the glucocerebrosidase locus on chromosome 1q21: implications for Gaucher disease.
|
| 31 |
methotrexate group
(2 回)
|
Biotechnology
生物工学, 生命工学
(1 回)
|
VitB17 (2 回)
DHFR (1 回)
RD (1 回)
|
2020 Vitamin B17 Ameliorates Methotrexate-Induced Reproductive Toxicity, Oxidative Stress, and Testicular Injury in Male Rats.
|
| 32 |
methotrexate monotherapy
(2 回)
|
Rheumatic Diseases
(2 回)
|
CHAQ (2 回)
JIA (2 回)
ACRp (1 回)
|
2019 Health-related quality of life during early aggressive treatment in patients with polyarticular juvenile idiopathic arthritis: results from randomized controlled trial.
|
| 33 |
methoxetrate
(2 回)
|
Rheumatology
リウマチ学
(2 回)
|
FACS (1 回)
IL (1 回)
JCA (1 回)
|
2002 Folinic acid antagonizes methotrexate-induced differentiation of monocyte progenitors.
|
| 34 |
methoxyflurane
(全身麻酔薬;ハロゲン化炭化水素系;揮発性) メトキシフルラン
(2 回)
|
Emergency Medicine
救急医学
(2 回)
|
INF (1 回)
IQR (1 回)
NRS (1 回)
|
2010 Inhaled methoxyflurane and intranasal fentanyl for prehospital management of visceral pain in an Australian ambulance service.
|
| 35 |
modulate the cytotoxicity of methotrexate
(2 回)
|
Neoplasms
新生物, 腫瘍
(2 回)
|
DP (1 回)
HX (1 回)
|
1987 Phase II trial of oral methotrexate and dipyridamole in colorectal carcinoma.
|
| 36 |
monotherapy, tofacitinib+methotrexate
(2 回)
|
Rheumatology
リウマチ学
(2 回)
|
CDAI (2 回)
CRP (1 回)
HAQ-DI (1 回)
|
2019 Very early MRI responses to therapy as a predictor of later radiographic progression in early rheumatoid arthritis.
|
| 37 |
MTX and calcium folinate (leucovorin) rescue therapy
(2 回)
|
Pharmacology
薬理学, 薬理, 薬品作用学
(1 回)
|
CL (1 回)
|
1999 Electrical stimulation prolongs the survival days of leukemic mice treated with methotrexate.
|
| 38 |
peptide-methotrexate
(2 回)
|
Science
科学
(1 回)
|
LHRH (1 回)
THPs (1 回)
|
1993 Selective coupling of methotrexate to peptide hormone carriers through a gamma-carboxamide linkage of its glutamic acid moiety: benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate activation in salt coupling.
|
| 39 |
5-deoxy-5-methylthio-xylofuranose
(1 回)
|
Chemistry
化学
(1 回)
|
LAM (1 回)
MSX (1 回)
|
2006 The 5-deoxy-5-methylthio-xylofuranose residue in mycobacterial lipoarabinomannan. absolute stereochemistry, linkage position, conformation, and immunomodulatory activity.
|
| 40 |
ABCG2-mediated transport of methotrexate
(1 回)
|
Biochemistry
生化学, 生物化学
(1 回)
|
ABC (1 回)
MDR (1 回)
TKI (1 回)
|
2009 Nilotinib (AMN107, Tasigna) reverses multidrug resistance by inhibiting the activity of the ABCB1/Pgp and ABCG2/BCRP/MXR transporters.
|
| 41 |
Antimetabolite-methotrexate
(1 回)
|
Biology
生物学
(1 回)
|
Glu-MTX (1 回)
|
2021 The Effect of a New Glucose-Methotrexate Conjugate on Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma Cell Lines.
|
| 42 |
dendrimer-methotrexate
(1 回)
|
Biochemistry
生化学, 生物化学
(1 回)
|
CHO (1 回)
DCC (1 回)
DHFR (1 回)
|
2006 Activity of dendrimer-methotrexate conjugates on methotrexate-sensitive and -resistant cell lines.
|
| 43 |
disease-modifying therapy received methotrexate
(1 回)
|
Medicine
医学, 医薬
(1 回)
|
CS (1 回)
RA (1 回)
sTLR2 (1 回)
|
2020 ASSOCIATIONS BETWEEN EFFICACY OF THE THERAPY AND CIRCADIAN FLUCTUATIONS OF ENDOTHELIAL NITRIC OXIDE SYNTHASE WITH TOLL-LIKE RECEPTORS 2 EXPRESSION, AND NOS3 POLYMORPHISM IN FEMALES WITH RHEUMATOID ARTHRITIS.
|
| 44 |
dsDNA-methotrexate
(1 回)
|
Biophysics
生物物理学
(1 回)
|
AFM (1 回)
HOPG (1 回)
|
2011 In situ evaluation of anticancer drug methotrexate-DNA interaction using a DNA-electrochemical biosensor and AFM characterization.
|
| 45 |
etanercept-methotrexate
(1 回)
|
Rheumatology
リウマチ学
(1 回)
|
DAS28 (1 回)
NRI (1 回)
|
2010 Two-year clinical and radiographic results with combination etanercept-methotrexate therapy versus monotherapy in early rheumatoid arthritis: a two-year, double-blind, randomized study.
|
| 46 |
glycan-methotrexate
(1 回)
|
Biochemistry
生化学, 生物化学
(1 回)
|
DHFR (1 回)
|
2006 High-mannose-type glycan modifications of dihydrofolate reductase using glycan-methotrexate conjugates.
|
| 47 |
insulin-methotrexate
(1 回)
|
Gastroenterology
胃腸病学
(1 回)
|
---
|
2004 Receptor binding characteristics and cytotoxicity of insulin-methotrexate.
|
| 48 |
LAM-methylthioxylose
(1 回)
|
Biochemistry
生化学, 生物化学
(1 回)
|
LAM (1 回)
MS (1 回)
Mtb (1 回)
|
2021 Structural implications of lipoarabinomannan glycans from global clinical isolates in diagnosis of Mycobacterium tuberculosis infection.
|
| 49 |
lipid-PEG-methotrexate
(1 回)
|
Biomedical Engineering
生物医工学
(1 回)
|
CPT (1 回)
NRs (1 回)
NSs (1 回)
|
2015 Self-Targeted, Shape-Assisted, and Controlled-Release Self-Delivery Nanodrug for Synergistic Targeting/Anticancer Effect of Cytoplasm and Nucleus of Cancer Cells.
|
| 50 |
macrophages treated with methotrexate
(1 回)
|
Complementary Therapies
補完医療, 補完療法
(1 回)
|
IL (1 回)
RANTES (1 回)
WPG (1 回)
|
2010 Wild Panax ginseng (Panax ginseng C.A. Meyer) protects against methotrexate-induced cell regression by enhancing the immune response in RAW 264.7 macrophages.
|
| 51 |
magnitude than methotrexate
(1 回)
|
Chemistry
化学
(1 回)
|
---
|
1991 Novel pyrrolo[2,3-d]pyrimidine antifolates: synthesis and antitumor activities.
|
| 52 |
major target of methotrexate
(1 回)
|
Hematology
血液学
(1 回)
|
ALL (1 回)
CCND1 (1 回)
DHFR (1 回)
|
2007 DNA variants in the dihydrofolate reductase gene and outcome in childhood ALL.
|
| 53 |
major toxic effects of methotrexate
(1 回)
|
Pediatrics
小児科学, 小児医学
(1 回)
|
---
|
1999 The extended oligoarticular subtype is the best predictor of methotrexate efficacy in juvenile idiopathic arthritis.
|
| 54 |
maltodextrin
(糖質) マルトデキストリン
(1 回)
|
Pharmacological Phenomena
(1 回)
|
BBD (1 回)
D-time (1 回)
FE (1 回)
|
2022 Rizatriptan-Loaded Oral Fast Dissolving Films: Design and Characterizations.
|
| 55 |
marrow to specific methotrexate
(1 回)
|
Neoplasms
新生物, 腫瘍
(1 回)
|
---
|
1977 The relative contribution of drug concentration and duration of exposure to mouse bone marrow toxicity during continuous methotrexate infusion.
|
| 56 |
material, the antitumor drug mitoxantrone
(1 回)
|
|
SERRS (1 回)
SERS (1 回)
|
2018 Thermal dewetting tunes surface enhanced resonance Raman scattering (SERRS) performance.
|
| 57 |
matrix to deliver methotrexate
(1 回)
|
Polymers
(1 回)
|
FTIR (1 回)
PBS (1 回)
TGA (1 回)
|
2021 Methotrexate-Loaded Gelatin and Polyvinyl Alcohol (Gel/PVA) Hydrogel as a pH-Sensitive Matrix.
|
| 58 |
MBD therapy with methotrexate
(1 回)
|
Urology
泌尿器科学
(1 回)
|
PEP (1 回)
|
1992 [Repair of skin defect after extensive resection for penile cancer: report of two cases, and clinical observation of patients with penile cancer at Mie University hospital].
|
| 59 |
measure the effect of methotrexate
(1 回)
|
Rheumatology
リウマチ学
(1 回)
|
IL-1beta (1 回)
mRNA (1 回)
RA (1 回)
|
1994 Mechanisms of methotrexate action in rheumatoid arthritis. Selective decrease in synovial collagenase gene expression.
|
| 60 |
mechanisms that underlie the methotrexate
(1 回)
|
Antineoplastic Agents
抗悪性腫瘍薬
(1 回)
|
TJ (1 回)
ZO-1 (1 回)
|
2010 Zonula Occludens-1 alterations and enhanced intestinal permeability in methotrexate-treated rats.
|
| 61 |
mediating the majority of methotrexate
(1 回)
|
Biochemistry
生化学, 生物化学
(1 回)
|
---
|
1995 Structural preferences among folate compounds and their analogues for ATPase-mediated efflux by inside-out plasma membrane vesicles derived from L1210 cells.
|
| 62 |
medical therapy combining multidose methotrexate
(1 回)
|
Medicine
医学, 医薬
(1 回)
|
CSP (1 回)
|
2015 Novel Medical Therapy of Cesarean Scar Pregnancy With a Viable Embryo Combining Multidose Methotrexate and Mifepristone: A Case Report.
|
| 63 |
Medical therapy involving methotrexate
(1 回)
|
General Surgery
外科学
(1 回)
|
EP (1 回)
|
2022 Short-term Reproductive Outcomes of Nulliparous Women with Previous Ectopic Pregnancy.
|
| 64 |
medical treatment with intramuscular methotrexate
(1 回)
|
Medicine
医学, 医薬
(1 回)
|
EGFR (1 回)
hCG (1 回)
tEP (1 回)
|
2013 Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol.
|
| 65 |
medical treatment with systemic methotrexate
(1 回)
|
Gynecology
婦人科学, 産婦人科学
(1 回)
|
ECA (1 回)
|
2014 The efficacy of the systemic methotrexate treatment in caesarean scar ectopic pregnancy: A quantitative review of English literature.
|
| 66 |
medication to methotrexate
(1 回)
|
Chronic Disease
(1 回)
|
AEs (1 回)
CI (1 回)
GSZD (1 回)
|
2021 Chinese traditional medicine (GuiZhi-ShaoYao-ZhiMu decoction) as an add-on medication to methotrexate for rheumatoid arthritis: a meta-analysis of randomized clinical trials.
|
| 67 |
medium-term effects of methotrexate
(1 回)
|
Pharmacology
薬理学, 薬理, 薬品作用学
(1 回)
|
---
|
2000 Additive effect of indomethacin and methotrexate on suppression of growth in rats.
|
| 68 |
metabolic turnover of methotrexate
(1 回)
|
Biochemistry
生化学, 生物化学
(1 回)
|
---
|
1992 Metabolic turnover of methotrexate polyglutamates in lysosomes derived from S180 cells. Definition of a two-step process limited by mediated lysosomal permeation of polyglutamates and activating reduced sulfhydryl compounds.
|
| 69 |
metaphylaxis
(1 回)
|
Therapeutics
治療学, 薬物療法学
(1 回)
|
BRD (1 回)
|
2008 Evaluation of on-arrival versus prompted metaphylaxis regimes using ceftiofur crystalline free acid for feedlot heifers at risk of developing bovine respiratory disease.
|
| 70 |
method to facilitate methotrexate
(1 回)
|
Pharmacology
薬理学, 薬理, 薬品作用学
(1 回)
|
---
|
1988 Effects of combination of vasodilator drugs and hypertonic solutions on methotrexate distribution into the rat brain.
|
| 71 |
method to monitor methotrexate
(1 回)
|
Chemistry Techniques, Analytical
分析化学法
(1 回)
|
CE (1 回)
CSF (1 回)
DAMPA (1 回)
|
2010 Analysis of methotrexate and its eight metabolites in cerebrospinal fluid by solid-phase extraction and triple-stacking capillary electrophoresis.
|
| 72 |
method to quantify methotrexate
(1 回)
|
Drug Therapy
薬物療法, 薬物治療
(1 回)
|
5500 Q-trap (1 回)
ACN (1 回)
ESI (1 回)
|
2021 A Validated HPLC-MS/MS Method for Quantification of Methotrexate and Application for Therapeutic Drug Monitoring in Children and Adults with Non-Hodgkin Lymphoma.
|
| 73 |
methodology to calculate methotrexate
(1 回)
|
Drug Therapy
薬物療法, 薬物治療
(1 回)
|
---
|
1996 A limited sampling method to estimate methotrexate pharmacokinetics in patients with rheumatoid arthritis using a Bayesian approach and the population data modeling program P-PHARM.
|
| 74 |
METHODS: Fifty-three patients receiving methotrexate
(1 回)
|
Rheumatology
リウマチ学
(1 回)
|
JAKis (1 回)
RA (1 回)
|
2022 Impact of Janus Kinase Inhibitors on Antibody Response to 13-Valent Pneumococcal Conjugate Vaccine in Patients with Rheumatoid Arthritis.
|
| 75 |
METHODS: In a randomised, double-blind, controlled trial, patients received placebo+MTX
(1 回)
|
Rheumatology
リウマチ学
(1 回)
|
OCR (1 回)
RA (1 回)
|
2012 Safety and efficacy of ocrelizumab in combination with methotrexate in MTX-naive subjects with rheumatoid arthritis: the phase III FILM trial.
|
| 76 |
METHODS: The concentration of methotrexate
(1 回)
|
Complementary Therapies
補完医療, 補完療法
(1 回)
|
BBB (1 回)
BCNU (1 回)
|
2001 Opening blood-brain-barrier by intracarotid infusion of papaverine in treatment of malignant cerebral glioma.
|
| 77 |
METHODS: The effects of maitotoxin
(1 回)
|
Physiology
生理学
(1 回)
|
EPPs (1 回)
|
2001 [Effects of maitotoxin on the transmission of neuromuscular junction in rats].
|
| 78 |
METHODS: The efficacy of methotrexate
(1 回)
|
Neoplasms
新生物, 腫瘍
(1 回)
|
---
|
2007 Antifolate pseudo-resistance due to elevated levels of thymidine and hypoxanthine in a commercial serum preparation.
|
| 79 |
methohexital sodium
メトヘキシタールナトリウム
(1 回)
|
Emergency Medicine
救急医学
(1 回)
|
---
|
1991 The efficacy and safety of methohexital in the emergency department.
|
| 80 |
Methortrexatum
(1 回)
|
Dentistry
歯学
(1 回)
|
5-FU (1 回)
E-ADM (1 回)
PYM (1 回)
|
2003 [Chemosensitivity testing of oral and maxillofacial cancer with biopsy specimens].
|
| 81 |
methotrexate administered
(1 回)
|
Rheumatology
リウマチ学
(1 回)
|
EORA (1 回)
LDA (1 回)
YORA (1 回)
|
2021 Consideration of differences in drug usage between young-onset and elderly-onset rheumatoid arthritis with target of low disease activity.
|
| 82 |
methotrexate concentrations
(1 回)
|
Antineoplastic Agents
抗悪性腫瘍薬
(1 回)
|
AKI (1 回)
HD-MTX (1 回)
|
2021 A pharmacologically-based approach to high dose methotrexate administration to investigate nephrotoxicity and acute kidney injury biomarkers in children and adolescents with newly diagnosed osteosarcoma.
|
| 83 |
methotrexate drug molecules
(1 回)
|
Chemistry
化学
(1 回)
|
HNTs (1 回)
|
2022 Prodrug based on halloysite delivery systems to improve the antitumor ability of methotrexate in leukemia cell lines.
|
| 84 |
methotrexate formulations
(1 回)
|
Nanotechnology
ナノテクノロジー
(1 回)
|
AIA (1 回)
LDE (1 回)
|
2013 Intra-articular methotrexate associated to lipid nanoemulsions: anti-inflammatory effect upon antigen-induced arthritis.
|
| 85 |
methotrexate injection
(1 回)
|
Complementary Therapies
補完医療, 補完療法
(1 回)
|
hCG (1 回)
UACE (1 回)
|
2021 Effect of Uterine Arterial Chemoembolization Combined with Ultrasound-Guided Uterine Curettage on Cervical Pregnancy and Influencing Factors.
|
| 86 |
methotrexate is correlated with the Ki
(1 回)
|
Biochemistry
生化学, 生物化学
(1 回)
|
---
|
1990 Transfection of DHFR- and DHFR+ mammalian cells using methotrexate-resistant mutants of mouse dihydrofolate reductase.
|
| 87 |
methotrexate tablets
(1 回)
|
Complementary Therapies
補完医療, 補完療法
(1 回)
|
DD (1 回)
ESR (1 回)
Fbg (1 回)
|
2018 [Acupuncture combined with western medicine on rheumatoid arthritis and effects on blood stasis].
|
| 88 |
methotrexate-based regimen
(1 回)
|
Neoplasms
新生物, 腫瘍
(1 回)
|
EI (1 回)
|
2019 Results of API-AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome-09 study.
|
| 89 |
methotrexate/week
(1 回)
|
Rheumatology
リウマチ学
(1 回)
|
---
|
1988 Severe reversible interstitial pneumonitis induced by low dose methotrexate: report of a case and review of the literature.
|
| 90 |
Methoxamine hydrochloride
メトキサミン塩酸塩, 塩酸メトキサミン
(1 回)
|
Biomedical Engineering
生物医工学
(1 回)
|
ASC (1 回)
HPLC (1 回)
LLOQ (1 回)
|
2007 Pharmacokinetic study of three cardiovascular drugs by high-performance liquid chromatography using pre-column derivatization with 9,10-anthraquinone-2-sulfonyl chloride.
|
| 91 |
methoxsalen
(光線療法剤;ソラレン系白斑治療) メトキサレン
(1 回)
|
Physiology
生理学
(1 回)
|
Ca (1 回)
CFTR (1 回)
|
2002 Methoxsalen stimulates electrogenic Cl- secretion in the mouse jejunum.
|
| 92 |
methylthio-d-xylose
(1 回)
|
Biochemistry
生化学, 生物化学
(1 回)
|
DP-MTX (1 回)
LAM (1 回)
|
2017 Biosynthesis of the Methylthioxylose Capping Motif of Lipoarabinomannan in Mycobacterium tuberculosis.
|
| 93 |
mg/kg. concentration-time profiles of methotrexate
(1 回)
|
Pharmacology
薬理学, 薬理, 薬品作用学
(1 回)
|
---
|
1995 The use of intracerebral microdialysis for the determination of pharmacokinetic profiles of anticancer drugs in tumor-bearing rat brain.
|
| 94 |
micro-textured
(1 回)
|
|
CFU (1 回)
GI (1 回)
GII (1 回)
|
2019 The Effect of Er,Cr:YSGG and Diode Laser Applications on Dental Implant Surfaces Contaminated with Acinetobacter Baumannii and Pseudomonas Aeruginosa.
|
| 95 |
microencapsulation, the composite methotrexate
(1 回)
|
Nanotechnology
ナノテクノロジー
(1 回)
|
---
|
2012 Formation of methotrexate-PLLA-PEG-PLLA composite microspheres by microencapsulation through a process of suspension-enhanced dispersion by supercritical CO2.
|
| 96 |
mini-methorexate
(1 回)
|
Hematology
血液学
(1 回)
|
allo-SCT (1 回)
AML/MDS (1 回)
AUC (1 回)
|
2010 Clofarabine fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS.
|
| 97 |
minimize toxicity of high-dose methotrexate
(1 回)
|
Biochemistry
生化学, 生物化学
(1 回)
|
---
|
2012 Discordance between urine pH measured by dipstick and pH meter: implications for methotrexate administration protocols.
|
| 98 |
Mitoxanthrone
(1 回)
|
Cardiology
心臓病学
(1 回)
|
ECG (1 回)
LVEF (1 回)
MS (1 回)
|
2015 Cardiac effects of mitoxanthrone therapy in patients with multiple sclerosis.
|
| 99 |
mitoxantron
(1 回)
|
Biological Science Disciplines
(1 回)
|
---
|
2022 Bioremoval and Detoxification of the Anticancer Drug Mitoxantrone Using Immobilized Crude Versatile Peroxidase (icVP/Ba) Bjerkandera adusta CCBAS 930.
|
| 100 |
Mitoxantrone HCl
(1 回)
|
Biology
生物学
(1 回)
|
FA (1 回)
|
2015 Folic acid-conjugated TiO2-doped mesoporous carbonaceous nanocomposites loaded with Mitoxantrone HCl for chemo-photodynamic therapy.
|
A Search Service for Abbreviation / Long Form